Simultaneous targeting of VEGF-receptors 2 and 3 with immunoliposomes enhances therapeutic efficacy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Simultaneous targeting of VEGF-receptors 2 and 3 with immunoliposomes enhances therapeutic efficacy

Published:2015-07-23 Issue:1 Volume:24 Page:80-89
ISSN:1061-186X
Container-title:Journal of Drug Targeting
language:en
Short-container-title:Journal of Drug Targeting

Author:

Orleth Annette¹²,Mamot Christoph²³,Rochlitz Christoph¹²,Ritschard Reto¹²,Alitalo Kari⁴,Christofori Gerhard²,Wicki Andreas¹²

Affiliation:

1. Department of Medical Oncology, University Hospital, Basel, Switzerland,

2. Department of Biomedicine, University of Basel, Basel, Switzerland,

3. Division of Medical Oncology, Cantonal Hospital, Aarau, Switzerland, and

4. Biomedicum Helsinki, Haartman Institute, University of Helsinki, Helsinki, Finland

Publisher

Informa UK Limited

Subject

Pharmaceutical Science

Link

https://www.tandfonline.com/doi/pdf/10.3109/1061186X.2015.1056189

Reference32 articles.

1. Antibody Targeting of Long-Circulating Lipidic Nanoparticles Does Not Increase Tumor Localization but Does Increase Internalization in Animal Models

2. Epidermal Growth Factor Receptor–Targeted Immunoliposomes Significantly Enhance the Efficacy of Multiple Anticancer DrugsIn vivo

3. Immunoliposomal delivery of doxorubicin can overcome multidrug resistance mechanisms in EGFR-overexpressing tumor cells

4. Notch-dependent VEGFR3 upregulation allows angiogenesis without VEGF–VEGFR2 signalling

5. Prognostic significance of the expression of vascular endothelial growth factors A, B, C, and D and their receptors R1, R2, and R3 in patients with nonsmall cell lung cancer

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual-loaded liposomal carriers to combat chemotherapeutic resistance in breast cancer;Expert Opinion on Drug Delivery;2024-01-31

2. Tumor vasculature vs tumor cell targeting: Understanding the latest trends in using functional nanoparticles for cancer treatment;OpenNano;2023-05

3. Future Trends and Innovation in Nano Drug Delivery for Cancer Therapy, Application of siRNA (Nanoparticle-Based RNA) Therapy, Ultrasound Linked Nano-Cancer Therapeutics, and Application of Exosomes-Based Cancer Therapy;Nano Drug Delivery for Cancer Therapy;2023

4. Smart Nanocarrier-Based Cancer Therapeutics;Therapeutic Approaches in Cancer Treatment;2023

5. Current nano-therapeutic approaches ameliorating inflammation in cancer progression;Seminars in Cancer Biology;2022-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3